Adam R. Metwalli, MD Great question! We (@eric_facs) discuss in an upcoming seminar in Urologic Oncology with awesome authors: Phillip Pierorazio DrBagrodia Kevin Turner Amy Luckenbaugh and more!

Investigating the clinical reasoning abilities of large language model GPT-4: an analysis of postoperative complications from renal surgeries buff.ly/3UQGK9R

Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer buff.ly/3wksLka

Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database buff.ly/3y4WYo1

Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI buff.ly/43DNsng

The assessment of bladder cancer resectability with bimanual palpation: A prospective study in laparoscopy and open cystectomy patients buff.ly/490FRjP

Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort buff.ly/43yvRgt

The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective buff.ly/3TFJhCZ

Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era buff.ly/48XyJ7K

Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review buff.ly/3TGSZpO

Table of Contents buff.ly/3waIaUg

Editorial Board buff.ly/3UAzFLD

Cover 2 - Masthead buff.ly/3Uzu1Z1

🚨Just published in Urologic Oncology our latest paper on the role of urinary cytology predicting risk category in #NMIBC by Cgdelcanizo
📖Read it here: t.ly/J3FKQ
UroSoMe

Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma buff.ly/3Wuh7y3

Network analysis of histopathological image features and genomics data improving prognosis performance in clear cell renal cell carcinoma buff.ly/3UuRv2n

Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma buff.ly/4aKXyFD

HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center buff.ly/3UtVzjj

Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer buff.ly/3xUODmv

Avoiding “Needless” nephrectomy: What is the role of small renal mass biopsy in 2024? buff.ly/3UfW7bA